Skip to content
Video: Three PrEP Myths Busted (One Pill Per Day to Prevent HIV)
Share on facebook
Share on google
Share on twitter
Share on linkedin
The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.
Demystifying HIV Pre-Exposure Prophylaxis
To improve health literacy and patient self-advocacy by providing patient-friendly educational information to HIV-positive people and their clinicians about ways to improve HIV treatment response, side effects
© 2019 PoWeR USA. All Rights Reserved.
Scroll to Top